Oncoustics aims to enhance the efficacy of cancer research and treatment by bringing to market novel ultrasound-based cancer treatment assessment technology. Our products will enable researchers, and eventually clinicians, to rapidly determine tumour response to therapy using standard ultrasound devices. Our technology can greatly increase the efficiency and productivity of cancer research and the drug discovery process.